HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jacques Robin Gérard Champsaur Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vedrinne, C. Articles by Champsaur, G. Search for Related Content PubMed PubMed Citation Articles by Vedrinne, C. Articles by Champsaur, G.

J Thorac Cardiovasc Surg 2000;120:770-777
© 2000 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease

Better preservation of endothelial function and decreased activation of the fetal renin-angiotensin pathway with the use of pulsatile flow during experimental fetal bypass

From the Departments of Anesthesia and Intensive Care Medicine in Cardiovascular Surgery^a and of Cardiovascular Surgery,^b Louis Pradel Cardiologic Hospital; the Physiology Laboratory,^d Faculty of Medicine Grange Blanche; and the National Veterinary School,^c Lyon, France.

Supported in part by a research grant (JE 1949) from Claude Bernard University, Lyon, France.

Address for reprints: C. Vedrinne, MD, Hopital Cardiologique Louis Pradel, 59 Boulevard Pinel, 69003, Lyon, France (E-mail: c-vedrin{at}univ-lyon1.fr).

Objective: Pulsatile flow was shown to overcome the progressive rise in peripheral and placental vascular resistances observed during steady-flow bypass, this rise being counteracted by inhibition of nitric oxide synthase. This study quantifies the release of endothelial vasoactive substances during a 60-minute in utero model of fetal bypass.
Methods: Fetuses were randomly allocated into 1 of 2 groups (steady flow, n = 8, or pulsatile flow, n = 13) and subjected to bypass through central cannulation and perfusion with either a centrifugal or pulsatile (125 beats · min^–1) blood pump.
Results: Lactate concentration was high, starting at fetal exteriorization and increasing during fetal preparation in the 2 groups. Once bypass was established, the rise was significant only in the steady-flow group. Plasma nitric oxide metabolites, similar before bypass, reached higher levels during pulsatile flow at the end of bypass (99 ± 9 vs 82 ± 23 µmol · L^–1; P = .037). Levels of urinary nitric oxide metabolites were significantly higher in the pulsatile-flow than in the steady-flow group (764 ± 143 vs 508 ± 240 µmol · L^–1; P = .005). Plasma cyclic guanosine monophosphate levels increased after 30 minutes of bypass in the pulsatile-flow group (25 ± 18 vs 12 ± 8 pmol · mL^–1; P = .004), and urinary cyclic guanosine monophosphate excretion was higher in the pulsatile-flow group (517 ± 450 vs 118 ± 78 pmol · mL^–1; P = .024). Plasma endothelin-1 levels increased in the 2 groups and were higher in the steady-flow group at 30 minutes (27 ± 5 vs 23 ± 2 pg · mL^–1; P = .04) and 60 minutes of bypass (39 ± 7 vs 32 ± 6 pg · mL^–1; P = .04). Plasma renin concentration increased significantly during bypass only in the steady-flow group (26 ± 10 vs 57 ± 42 in ng A1 · mL^–1 · h^–1; P = .04).
Conclusions: Improved placental and peripheral perfusion during fetal pulsatile-flow bypass may be mediated by preservation of fetal/maternal endothelial nitric oxide biosynthetic mechanisms and/or decreased activation of the fetal renin-angiotensin pathway.

This article has been cited by other articles:

				F. Onorati, G. Santarpino, G. Tangredi, G. Palmieri, A. S. Rubino, D. Foti, E. Gulletta, and A. Renzulli Intra-aortic balloon pump induced pulsatile perfusion reduces endothelial activation and inflammatory response following cardiopulmonary bypass Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 1012 - 1019. [Abstract] [Full Text] [PDF]

				E. A. Heeb, R. S. Baker, C. Lam, M. Basu, W. Lubbers, J. Y. Duffy, and P. Eghtesady Role of Natriuretic Peptides in cGMP Production in Fetal Cardiac Bypass. Ann. Thorac. Surg., March 1, 2009; 87(3): 841 - 847. [Abstract] [Full Text] [PDF]

				C. Lam, R. S. Baker, J. McNamara, R. Ferguson, J. Lombardi, K. Clark, and P. Eghtesady Role of Nitric Oxide Pathway in Placental Dysfunction Following Fetal Bypass Ann. Thorac. Surg., September 1, 2007; 84(3): 917 - 925. [Abstract] [Full Text] [PDF]

				N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF]

				J. Lombardi, J. Sedgwick, J. Schenbeck, W. Lubbers, R. E Ferguson, A. Gardner, J. L McNamara, and P. Eghtesady Cardiopulmonary bypass in the immature fetus through novel use of a mini-centrifugal pump Perfusion, May 1, 2006; 21(3): 185 - 191. [Abstract] [PDF]

				Y. Oishi, M. Masuda, T. Yasutsune, N. Boku, S. Tokunaga, S. Morita, and H. Yasui Impaired Endothelial Function of the Umbilical Artery After Fetal Cardiac Bypass Ann. Thorac. Surg., December 1, 2004; 78(6): 1999 - 2003. [Abstract] [Full Text] [PDF]

				A. Carotti, F. Emma, S. Picca, E. Iannace, S. B. Albanese, M. Grigioni, F. Meo, M. Sciarra, and R. M. Di Donato Inflammatory response to cardiac bypass in ewe fetuses: effects of steroid administration or continuous hemodiafiltration J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1839 - 1848. [Abstract] [Full Text] [PDF]